ISCO International Stem Cell CORP: institutional ownership and insider trading
Over the last 12 months insiders bought $0 and sold $10.5K on the open market; over its last four quarters it reported revenue of $9.51M and net income of −$582K.
ISCO revenue and earnings
- Quarter ended Jun 30, 2026: revenue $2.68M, net income −$71.0K, EPS -0.01
- Quarter ended Mar 31, 2026: revenue $2.32M, net income −$220K, EPS -0.03
- Quarter ended Dec 31, 2025: revenue $2.16M, net income −$348K, EPS -0.03
- Quarter ended Sep 30, 2025: revenue $2.37M, net income $57.0K, EPS 0.00
Recent ISCO insider trades
- Sep 11, 2026: Maier Paul V sold 32,802 shares ($10.5K)
Are insiders buying or selling ISCO?
Over the last 12 months insiders bought $0 and sold $10.5K of International Stem Cell CORP stock on the open market (SEC Form 4).
What was ISCO's revenue last quarter?
International Stem Cell CORP reported revenue of $2.68M for the quarter ended June 30, 2026, with net income of −$71.0K.